scispace - formally typeset
Search or ask a question
Topic

Cytotoxic T cell

About: Cytotoxic T cell is a research topic. Over the lifetime, 92492 publications have been published within this topic receiving 4768477 citations. The topic is also known as: killer T cell & cytotoxic T lymphocyte.


Papers
More filters
Journal ArticleDOI
01 Aug 2004-Blood
TL;DR: Insight is provided into the pathophysiology of HLH, new targets for specific therapeutic intervention in this fatal disorder are provided, and the excessive amount of IFNgamma seen in affected mice appears to be driven by increased antigen presentation to CD8+ T cells.

599 citations

Journal Article
TL;DR: It is observed that pyran, lipopolysaccharide, and polyinosinicopolycytidylic acid as well as crude and purified IF preparations significantly elevated splenic NK levels in normal mice within 3 to 24 hr of i.p. administration, indicating that IF acts on lymphocytes to activate NK function.
Abstract: Interferon (IF), in addition to its anti-viral capacity, is increasingly being found to be a regulator of cell division, cell surface antigens, and cell function. To determine whether IF also plays a role in the regulation of natural killer (NK) cell activity in mice, the in vivo and in vitro effects of IF and IF inducers on NK activity were studied. We observed that pyran, lipopolysaccharide, and polyinosinicopolycytidylic acid (poly I:C) as well as crude and purified IF preparations significantly elevated splenic NK levels in normal mice within 3 to 24 hr of i.p. administration. Normal spleen cells treated with poly I:C or IF in vitro also had augmented NK activity. Poly I:C and IF were themselves not cytotoxic and their presence was not required during the lytic process, indicating that IF acts on lymphocytes to activate NK function. The addition of anti-IF in the incubation medium completely blocked the boosting of NK activity by poly I:C or IF. The characteristics of the effector cells activated by IF were consistent with those of NK cells rather than macrophages, since the boosted effector cells were not retained by a rayon column or removed by carbonyl iron. Moreover, they were resistant to treatment with anti-Thy 1.2 serum plus complement, which eliminated mature T cells.

599 citations

Journal ArticleDOI
01 May 1998-Immunity
TL;DR: The ability of IL-2 to enhance expression of a pro-apoptotic molecule, FasL, and to suppress an inhibitor of Fas signaling, FLIP, likely accounts for the role of this cytokine in potentiating T cell apoptosis.

598 citations

Journal ArticleDOI
TL;DR: The results indicate that miR-150 most likely down-regulates mRNAs that are important for pre- and pro-B cell formation or function, and its ectopic expression in these cells blocks further development of B cells.
Abstract: MicroRNAs (miRNAs) are a family of ≈22-nt noncoding RNAs that can posttranscriptionally regulate gene expression. Several miRNAs are specifically expressed in hematopoietic cells. Here we show that one such miRNA, miR-150, is mainly expressed in the lymph nodes and spleen and is highly up-regulated during the development of mature T and B cells; expression of miR-150 is sharply up-regulated at the immature B cell stage. Overexpression of miR-150 in hematopoietic stem cells, followed by bone marrow transplantation, had little effect on the formation of either mature CD8- and CD4-positive T cells or granulocytes or macrophages, but the formation of mature B cells was greatly impaired. Furthermore, premature expression of miR-150 blocked the transition from the pro-B to the pre-B stage. Our results indicate that miR-150 most likely down-regulates mRNAs that are important for pre- and pro-B cell formation or function, and its ectopic expression in these cells blocks further development of B cells.

598 citations

Journal ArticleDOI
01 Jun 1999-Immunity
TL;DR: The telomerase catalytic subunit (hTERT) is characterized as a widely expressed TAA capable of triggering antitumor cytotoxic T lymphocyte (CTL) responses and identified as a potentially important and widely applicable target for anticancer immunotherapeutic strategies.

598 citations


Network Information
Related Topics (5)
T cell
109.5K papers, 5.5M citations
94% related
Immune system
182.8K papers, 7.9M citations
93% related
Cytokine
79.2K papers, 4.4M citations
93% related
Cell culture
133.3K papers, 5.3M citations
92% related
Antigen
170.2K papers, 6.9M citations
91% related
Performance
Metrics
No. of papers in the topic in previous years
YearPapers
20251
20241
20234,029
20224,295
20212,914
20202,932